Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
The company last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 1.56 M for the quarter and had revenue of 23.34 M for the year. The company has generated $-72 earnings per share over the last year ($-71.5 diluted earnings per share) and currently has a price-to-earnings ratio of -0.04. The company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/19/2026 | Q1 2026 | N/A | -$3.70 | N/A | N/A | $1.56 M |
| 03/20/2026 | Q4 2025 | N/A | -$13.50 | N/A | N/A | $1.67 M |
| 11/19/2025 | Q3 2025 | N/A | -$23.00 | N/A | N/A | $3.01 M |
| 08/19/2025 | Q2 2025 | N/A | -$5.50 | N/A | N/A | $7.79 M |
| 05/12/2025 | Q1 2025 | N/A | -$31.00 | N/A | N/A | $10.86 M |
| 03/25/2025 | Q4 2024 | N/A | -$4.17 | N/A | $2.54 M | $-16,048,214 |
| 09/30/2024 | Q3 2024 | N/A | -$1.80 | N/A | $2.48 M | $15.80 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.56 | N/A | $2.24 M | $10.44 M |
| 03/31/2024 | Q1 2024 | N/A | -$1.82 | N/A | N/A | $7.94 M |
| 12/31/2023 | Q4 2023 | N/A | -$12.60 | N/A | N/A | $34.37 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.87 | N/A | $2.28 M | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.41 | N/A | $2.06 M | $0 |
The conference call for 's latest earnings report can be listened to online.
The conference call transcript for 's latest earnings report can be read online.
(:MEDS) has a recorded annual revenue of $23.34 M.
(:MEDS) has a recorded net income of $-101,274,530. has generated $-71.5 earnings per share over the last four quarters.
(:MEDS) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED